Longitude Capital Partners III, LLC Insider Trading $SRRA Sierra Oncology, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Longitude Capital Partners III, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in Sierra Oncology, Inc. ($SRRA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in 89bio, Inc. ($ETNB) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).

Longitude Capital Partners III, LLC in Sierra Oncology, Inc.

Trading Symbol: SRRA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Longitude Capital Partners III, LLC: 10% Owner
Holdings: 1,477,320 shares
Latest Transaction: Jan 31 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Longitude Capital Partners III, LLC in Sierra Oncology, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 31 2020SRRASierra Oncology, I ...Longitude Capital Partners III ...10% OwnerOption ExerciseC0.0019,50000
Jan 31 2020SRRASierra Oncology, I ...Longitude Capital Partners III ...10% OwnerBuyC0.001,477,32001,477,3200 to 1.5 M

Page:   1